SK Capital Reaches Agreement to Sell Milestone Environmental to I Squared Capital
Apotex
Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
Genetix
Genetix Biotherapeutics and SPIMACO Announce Strategic Agreement to Commercialize and Manufacture LYFGENIA™ & ZYNTEGLO™ in Saudi Arabia and the Broader Middle East Region
Apotex
Apotex Health Corp. Announces Closing of Upsized Initial Public Offering and Exercise of Over-Allotment Option in Full
Isolatek
SK Capital Completes the Sale of Isolatek International to Catchment Capital
Acquisitions, Swixx
Swixx Completes Strategic Investment From SK Capital and Bain Capital Life Sciences to Support Continued Global Expansion